Diligence memo · auto-generated · as of July 2, 2026
Forma Therapeutics Inc
Forma Therapeutics Inc looks under-valued against its niche peers and is dormant on financing cadence.
Businessfiled
Forma Therapeutics Inc operates in Biotechnology, based in CAMBRIDGE.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Forma Therapeutics Inc has raised $28M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Series B (a $15M–$40M round).
Largest single filing: $25M on 2009-11-16.
Most recent recorded round closed around 2009-12-10.
Valuation (modeled)modeled
Provath models Forma Therapeutics Inc at approximately $119M (range $6.0M–$458M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.13× the median modeled value of Series B Biotechnology companies in 2007–2009 (21 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 1 months.
Last raise 16.6 yr ago; this sector typically re-raises about every 14 months.
Silent for over 3× the sector's normal cadence.
The last round was 8.5× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 74% of Biotechnology peers (4293 compared).
Modeled value ranks above 62% of those peers.
Closest niche peers: Ion Torrent Systems Inc, PhotoThera Inc, Taligen Therapeutics Inc, Atritech Inc, Barosense Inc.
Peoplefiled
1 named person on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.